IRIDEX Corporation

IRIX

US4626841013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
2.85 ^USD	-0.35%		-5.94%	+1.42%

Mar. 26	Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024
Mar. 26	Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M	MT

IRIDEX Corporation(NasdaqGM:IRIX) dropped from Russell 3000E Value Index

June 23, 2023 at 12:00 am EDT

Latest news about IRIDEX Corporation

Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024	Mar. 26
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M	Mar. 26	MT
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 26	CI
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter Ended December 30, 2023	Mar. 26	CI
North American Morning Briefing : Markets Steady -2-	Mar. 26	DJ
Iridex Corporation Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust	Jan. 24	CI
Iridex Corporation Launches New Iridex 532 and Iridex 577 Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma	Jan. 11	CI
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	Nov. 27	CI
Transcript : IRIDEX Corporation, Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q3 Revenue $12.9M, vs. Street Est of $13.5M	Nov. 14	MT
IRIDEX Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
IRIDEX Corporation Withdraws Previously Announced Guidance for 2023	Nov. 14	CI
Wall Street Set to Open Mixed Ahead of Federal Reserve Meeting	Nov. 01	MT
IRIDEX Hires Advisers to Explore Strategic Alternatives	23-08-29	MT
Iridex Announces Strategic Review to Unlock Shareholder Value	23-08-29	CI
Transcript : IRIDEX Corporation, Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
IRIDEX Corporation Reports Earnings Results for the Second Quarter and Six Months Ended July 01, 2023	23-08-10	CI
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q2 Revenue $12.9M, vs. Street Est of $14.2M	23-08-10	MT
IRIDEX Corporation Provides Revenue Guidance for the Year 2023	23-08-10	CI
IRIDEX Corporation(NasdaqGM:IRIX) dropped from Russell Microcap Value Index	23-06-23	CI
IRIDEX Corporation(NasdaqGM:IRIX) dropped from Russell 3000E Value Index	23-06-23	CI
Transcript : IRIDEX Corporation, Q1 2023 Earnings Call, May 11, 2023	23-05-11
IRIDEX Corporation Reports Earnings Results for the First Quarter Ended April 01, 2023	23-05-11	CI
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q1 Revenue $13.7M, vs. Street Est of $13.6M	23-05-11	MT
IRIDEX Corporation Reiterates Financial Guidance for 2023	23-05-11	CI

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for IRIDEX Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.85 USD

Average target price

2 USD

Spread / Average Target

-29.82%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
IRIDEX CORPORATION	+1.42%	46.32M
THERMO FISHER SCIENTIFIC	+7.15%	217B
DANAHER CORPORATION	+6.60%	183B
INTUITIVE SURGICAL, INC.	+9.86%	131B
BOSTON SCIENTIFIC CORPORATION	+24.32%	106B
SIEMENS HEALTHINEERS AG	-0.95%	62.16B
EDWARDS LIFESCIENCES CORPORATION	+11.04%	51.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.89B
AGILENT TECHNOLOGIES, INC.	-1.43%	40.16B
RESMED, INC.	+24.40%	31.44B

Other Advanced Medical Equipment & Technology